Cardurion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the treatment of cardiovascular disease and heart failure. Its research and development pipeline centers on novel small-molecule programs including PDE9 inhibition for chronic heart failure (HFrEF and HFpEF) and CaMKII inhibition for cardiac diseases… - View it on GitHub